TFF Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$2.26 | -$2.26 | -$2.26 |
| Q2 2024 | 1 | -$1.70 | -$1.70 | -$1.70 |
| Q3 2024 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q4 2024 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q1 2025 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q2 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
TFF Pharmaceuticals, Inc. Earnings Date And Information
TFF Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 20th, 2024. The company reported $-0.81 earnings per share for the quarter, missing analysts' consensus estimates of $-0.81 by $0. The company had revenue of 193,387 for the quarter and had revenue of 733,871 for the year. TFF Pharmaceuticals, Inc. has generated $-12 earnings per share over the last year ($-11.85 diluted earnings per share) and currently has a price-to-earnings ratio of -0.08. TFF Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
TFF Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/20/2024 | Q3 2024 | -$0.81 | -$0.81 | 0 | $150,000 | $193,387 |
| 08/14/2024 | Q2 2024 | -$1.70 | -$1.22 | 0.48 | $150,000 | $650,222 |
| 05/14/2024 | Q1 2024 | -$2.20 | -$2.40 | -0.2 | $203,273 | |
| 03/28/2024 | Q4 2023 | -$2.00 | -$2.01 | -0.01 | $733,871 | |
| 11/14/2023 | Q3 2023 | -$2.75 | -$2.32 | 0.43 | $50,000 | $0 |
| 08/14/2023 | Q2 2023 | -$3.47 | $66,667 | $333,351 | ||
| 05/11/2023 | Q1 2023 | -$5.00 | -$4.76 | 0.24 | $51,429 | |
| 03/31/2023 | Q4 2022 | -$5.10 | $0 | |||
| 11/14/2022 | Q3 2022 | -$7.75 | -$0.29 | 7.46 | $0 | |
| 08/11/2022 | Q2 2022 | -$8.00 | -$0.34 | 7.66 | $0 | |
| 05/11/2022 | Q1 2022 | -$9.50 | -$0.33 | 9.17 | $0 | |
| 03/24/2022 | Q4 2021 | -$7.50 | -$0.40 | 7.1 | $0 | |
| 11/15/2021 | Q3 2021 | -$3.50 | -$0.34 | 3.16 | $1.70 M | $0 |
| 08/12/2021 | Q2 2021 | -$7.00 | -$0.18 | 6.82 | $0 | |
| 05/13/2021 | Q1 2021 | -$6.00 | -$0.33 | 5.67 | $0 | |
| 03/10/2021 | Q4 2020 | -$5.75 | -$0.26 | 5.49 | $0 | |
| 11/05/2020 | Q3 2020 | -$5.00 | -$0.24 | 4.76 | $500,000 | $0 |
| 08/13/2020 | Q2 2020 | -$5.25 | -$0.20 | 5.05 | $0 | |
| 05/14/2020 | Q1 2020 | -$6.00 | -$0.20 | 5.8 | $0 | |
| 03/26/2020 | Q4 2019 | -$0.33 | $0 |
TFF Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is TFF Pharmaceuticals, Inc.'s earnings date?
TFF Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
How can I listen to TFF Pharmaceuticals, Inc.'s earnings conference call?
The conference call for TFF Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read TFF Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for TFF Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does TFF Pharmaceuticals, Inc. generate each year?
TFF Pharmaceuticals, Inc. (:TFFP) has a recorded annual revenue of $733,871.
-
How much profit does TFF Pharmaceuticals, Inc. generate each year?
TFF Pharmaceuticals, Inc. (:TFFP) has a recorded net income of $733,871. TFF Pharmaceuticals, Inc. has generated $-11.85 earnings per share over the last four quarters.
-
What is TFF Pharmaceuticals, Inc.'s price-to-earnings ratio?
TFF Pharmaceuticals, Inc. (:TFFP) has a price-to-earnings ratio of -0.08 and price/earnings-to-growth ratio is -0.
